Microbiome and Health

While in Romania, I bought this amazing book: “Microbiomul: Sănătatea Începe în Intestin” by Prof. Dr. Maria Rescigno, in a Romanian translation of the original Italian book “Microbiota Geniale: Curare l’intestino per guarire la mente” (2023). I find the content very well explained to laypeople. The book is a fountain of new information that should […]

Synbiotics and Short-Chain Fatty Acid (SCFA) Production

Synbiotics are combinations of probiotics (live beneficial bacteria) and prebiotics (non-digestible fibers that feed them), designed to synergistically improve gut health. They enhance SCFA production—primarily acetate, propionate, and butyrate—more effectively than probiotics or prebiotics alone by providing both the microbes and their preferred substrates for fermentation in the colon. This synergistic combination boosts microbial diversity, […]

Prebiotics and Probiotics

Prebiotics vs. Probiotics: Key Differences and Benefits Both prebiotics and probiotics support gut health in complementary ways: Probiotics introduce live beneficial bacteria, while prebiotics nourish existing ones. Often combined as synbiotics for enhanced effects, they promote microbiome balance, which is linked to digestion, immunity, and more. Below is a comparison based on recent expert guidance.  […]

Dietary Sources of Short-Chain Fatty Acids (SCFAs)

You may wonder what the dietary sources of short-chain fatty acids (SCFAs) are, since they are so important in promoting overall health and longevity. Short-chain fatty acids (SCFAs)—primarily acetate, propionate, and butyrate—are mostly produced endogenously by gut bacteria through the process of dietary fiber fermentation. However, small amounts are available directly from certain foods. Direct […]

What Are Short-Chain Fatty Acids SCFAs

What are Short-Chain Fatty Acids (SCFAs) and what role do they play in our overall health? They play an enormous role in our health, encompassing gut health, metabolism, immunity, cardiovascular health, musculoskeletal health, neurological health, and mental health and wellbeing. Short-chain fatty acids (SCFAs), mainly acetate, propionate, and butyrate, are produced by our gut microbiota […]

Therapeutic Potential of Short Chain Fatty Acids

Short-chain fatty acids (SCFAs), such as acetate, propionate, and butyrate, exhibit broad therapeutic potential across multiple disease categories, including neurodegenerative and demyelinating conditions. They primarily act through mechanisms like G-protein-coupled receptor (GPCR) activation (e.g., GPR41/43/109A), histone deacetylase (HDAC) inhibition, anti-inflammatory effects (e.g., Treg promotion, NF-κB suppression), and metabolic regulation (e.g., AMPK activation for lipid/glucose homeostasis). […]

Sources of Dietary Fibers

Knowing the sources of dietary fibers that the Gut Microbiome ferments into short-chain fatty acids (SCFAs) can change your life and health. Our gut bacteria produce short-chain fatty acids (SCFAs), such as acetate, propionate, and butyrate, through the fermentation of non-digestible carbohydrates, including soluble and fermentable dietary fibers. These fibers are found in various plant-based […]

Promising Therapy in Alzheimer’s Disease

Short-chain fatty acids (SCFAs), including acetate, propionate, and butyrate, emerge as promising therapeutic agents in Alzheimer’s disease (AD). Short-chain fatty acids are produced by gut microbiota fermentation of dietary fibers. These SCFAs play a complex role in Alzheimer’s disease (AD) through the microbiota-gut-brain axis. AD patients exhibit gut dysbiosis with reduced SCFA-producing bacteria (e.g., Faecalibacterium […]

Gut Dysbiosis in Alzheimer’s Disease

Gut dysbiosis, marked by diminished microbial diversity and imbalanced bacterial composition, is a hallmark of Alzheimer’s disease (AD) AD often emerges in prodromal stages like mild cognitive impairment (MCI) and contributes to pathogenesis through the microbiota-gut-brain axis. AD patients show consistent reductions in short-chain fatty acid (SCFA)-producing taxa and enrichments in pro-inflammatory genera, correlating with […]

Gut Dysbiosis in Parkinson’s Disease

Gut dysbiosis is characterized by reduced microbial diversity and shifts in bacterial composition. It is a prominent feature in Parkinson’s disease (PD), often preceding motor symptoms by years and contributing to disease initiation and progression via the microbiota-gut-brain axis. PD patients exhibit consistent alterations, including depletion of short-chain fatty acid (SCFA)-producing bacteria and enrichment of […]